510(k) Report

510(k) · Cleared

Cleared

Iris Medical IQ 810 Photocoagulator

K040209510(k) TraditionalCleared Sep 20, 2004234-day reviewClass II21 CFR 886.4390

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iridex Corp · HQF Laser, Ophthalmic

Cleared on Sep 20, 2004 as substantially equivalent to K020374 (Iridex Corp, 2002) after a 234-day review. Its family tree reaches back 3 generations to 1989.

Decided
Sep 20, 2004
Review
234 days
Class
Class II
Product code
HQF
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K894841 (1989). 9 ancestors in all, the oldest K890086 (1989). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestor1991: 3 other ancestors1989: 1 other ancestor1994: 1 other ancestorK894841 · Iris Oculight (TM) SL · Iriderm Div. · 1989K960971 · Oculight GL · Iriderm Div. · 1996K020374 · Oculight SL/SLX · Iridex Corp · 200219851990199520002005
Other ancestors, by generation 2 generations back: 3 other ancestors3 generations back: 3 other ancestors K020374 · Oculight SL/SLX · Iridex Corp · 2002K960971 · Oculight GL · Iriderm Div. · 1996K894841 · Iris Oculight (TM) SL · Iriderm Div. · 19890
  1. Root · 3 generations backK894841 Iris Oculight (TM) SLIriderm Div. · 1989
  2. 2 generations backK960971 Oculight GLIriderm Div. · 1996
  3. 1 generation backK020374 Oculight SL/SLXIridex Corp · 2002
  4. This deviceK040209 Iris Medical IQ 810 PhotocoagulatorIridex Corp · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K894841Iris Oculight (TM) SLIriderm Div.1989—
−2K960971Oculight GLIriderm Div.1996—
−1K020374Oculight SL/SLXIridex Corp2002—
0 (this device)K040209Iris Medical IQ 810 PhotocoagulatorIridex Corp2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199130
199410
200210
FIG. 1 — Lineage of K040209, 1989–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQF device

  1. #1 K251772 Navilas Laser System 577sl (156691)score 13.6 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K020374Oculight SL/SLX
Summary page 5
…antially equivalent to other currently legally marketed ophthalmology laser devices including IRIDEX Corporation's IRIS Medical OcuLight SLx Laser Photocoagulator (K020374). Device Description The IQ 8 10 is a semiconductor diode laser system that delivers infrared 8 10 nm laser light intende…
Iridex Corp2002—

Also cleared against K020374: 8 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 2 companies; a new generation was cleared every 5.7 years on median.
  • None of the 9 ancestors has a recall.
  • 8 other devices also cite its predicate K020374.

How does its category compare?

All HQF devices

HQF Laser, Ophthalmic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HQF

3in 2025

2007: 42008: 32009: 72010: 22011: 42012: 52013: 62014: 32015: 42016: 32017: 32018: 12019: 42020: 42021: 12022: 72023: 52024: 32025: 32026 (partial year): 2
2007high 7 (2009) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQF

264in 2025

2007: 198 days median2008: 28 days median2009: 115 days median2011: 128 days median2012: 179 days median2013: 225 days median2014: 215 days median2015: 295 days median2016: 271 days median2017: 189 days median2019: 107 days median2020: 53 days median2022: 86 days median2023: 155 days median2024: 167 days median2025: 264 days median
2007high 295 (2015) · low 28 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQF

1in 2025

2007: 22008: 12009: 22010: 32011: 52012: 12013: 22014: 42025: 1
2007high 5 (2011) · low 0 (2015)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQF

106in 2025

2007: 602008: 342009: 332010: 432011: 262012: 412013: 392014: 582015: 802016: 1082017: 772018: 822019: 662020: 722021: 1002022: 1112023: 922024: 752025: 106
2007high 111 (2022) · low 26 (2011)2025

MAUDE reports naming product code HQF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074198260
2008328134
20097115233
20102—343
20114128526
20125179141
20136225239
20143215458
20154295080
201632710108
20173189077
20181—082
20194107066
2020453072
20211—0100
20227860111
20235155092
20243167075
202532641106
20262—0—

What is it indicated for?

The IRIDEX IQ 810 is indicated for retinal photocoagulation, laser trabeculoplasty, transscleral cyclophotocoagulation, transscleral retinal photocoagulation, iridotomy, and other laser diode treatments. The following are examples of applications for the IQ 810. Diabetic Retinopathy (Nonproliferative Retinopathy, Macular Edema, Proliferative Retinopathy): Panretinal Photocoagulation (PRP); Focal and Grid Laser Treatments Glaucoma (Primary Open Angle…

Read the full statement (140 words)

The IRIDEX IQ 810 is indicated for retinal photocoagulation, laser trabeculoplasty, transscleral cyclophotocoagulation, transscleral retinal photocoagulation, iridotomy, and other laser diode treatments. The following are examples of applications for the IQ 810.

Diabetic Retinopathy (Nonproliferative Retinopathy, Macular Edema, Proliferative Retinopathy): Panretinal Photocoagulation (PRP); Focal and Grid Laser Treatments

Glaucoma (Primary Open Angle, Closed Angle, Refractory Glaucoma [recalcitrant/uncontrolled]): Laser Trabeculoplasty; Iridotomy; Transscleral Cyclophotocoagulation (TSCPC)

Retinal Tears, Detachments, and Holes: Transscleral Retinal Photocoagulation (TSRPC); Focal and Grid Laser Treatments

Lattice Degeneration: PRP; Focal and Grid Laser Treatments

Age-related Macular Degeneration (AMD) with Choroidal Neovascularization (CNV): Focal and Grid Laser Treatments

Intra-Ocular Tumors (Choroidal Hemangioma, Choroidal Melanoma, Retinoblastoma): Focal and Grid Laser Treatments

Retinopathy of Prematurity: PRP; TSRPC; Focal and Grid Laser Treatments

Sub-Retinal (choroidal) Neovascularization: Focal and Grid Laser Treatments

Central and Branch Retinal Vein Occlusion: PRP; Focal and Grid Laser Treatments

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K040209: Iris Medical IQ 810 Photocoagulator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K040209

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026